EKR Therapeutics Overview
- Founded
- 2006
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Latest Deal Amount
- $150M
EKR Therapeutics General Information
Description
Developer of prescription products intended to serve the needs of the acute-care hospital setting. The company's products support the life of cancer patients, offer short-term treatment of hypertension and management of various AMI related conditions, enabling patients to get access to preferred treatment at a cost effective manner.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Acquirer
Primary Office
- Third Floor
- Bedminster Township
- NJ 07921
- United States
+1 (877) 000-0000
EKR Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 27-Jun-2012 | $150M | 00000 | 00000 | Completed | Generating Revenue |
| 4. Later Stage VC (Series D) | 10-Mar-2008 | 00000 | 00000 | Completed | Startup | |
| 3. Later Stage VC (Series C) | 22-Aug-2007 | 000.00 | 000.00 | Completed | Startup | |
| 2. Early Stage VC (Series B) | 15-Nov-2006 | $7.33M | $7.33M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 27-Jun-2006 | Completed | Startup |
EKR Therapeutics Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Commerce Health Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| ESP Equity Partners | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Garden State Life Sciences Venture Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
| LLR Partners | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| MPM Capital | Venture Capital | Minority | 000 0000 | 000000 0 |